Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
ESC Congress is the place where latest findings and original research are not just presented but reviewed and discussed.
Late-Breaking Science Online Submission Service is open
Deadline to submit is 21 May 2017.
Submission is only possible online via the link provided, you will need to log in to the Online Service using your My ESC account.
Important: Consult the submission rules and guidelines
Deadline to submit is 21 May 2017 (the deadline has been extended this year to allow for the latest results to be submitted)
21 May 2017: Late-Breaking Science submission deadlineMid-June 2017: Late-Breaking Science results. An email will be sent to each submitter and assigned presenter.End of June 2017: Deadline to confirm the presentation and submit the agreement form.
Late-Breaking Clinical Trial: Reserved for first presentations of the primary endpoint(s) of a novel clinical trial Late-Breaking Registry Results: Reserved for presentations of new Registry or new data / analyses from a registry. Data not previously presentedClinical Trial Update: Reserved for presentations of new data or secondary analysis of a trial where the primary data have been presented previouslyBasic and Translational Hot Line: Presenting the latest and "hottest" findings of studies in basic and translational cardiovascular science
© 2017 European Society of Cardiology. All rights reserved